In the BioHarmony Drug Report Database

"Preview" Icon

Cevimeline

Evoxac (cevimeline) is a small molecule pharmaceutical. Cevimeline was first approved as Evoxac on 2000-01-11. It is used to treat xerostomia in the USA. It is known to target muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M1, muscarinic acetylcholine receptor M4, and muscarinic acetylcholine receptor M3.

 

Trade Name

 

Evoxac
 

Common Name

 

cevimeline
 

ChEMBL ID

 

CHEMBL168815
 

Indication

 

xerostomia
 

Drug Class

 

Cholinergic agonists (arecoline derivatives used in treatment of Alzheimer disease)

Image (chem structure or protein)

Cevimeline structure rendering